Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.47 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31212713 | 0.93 | TSHR (0.57) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL18678359 | 0.91 | ALDH1A1 (0.51) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL531065 | 0.91 | ALDH1A1 (0.55) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL532332 | 0.91 | MAPT (0.59) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL531064 | 0.91 | ALDH1A1 (0.55) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL148266 | 0.91 | MAPT (0.59) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL29740662 | 0.90 | MAPT (0.57) | MAPTALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL168393 | 0.90 | ALDH1A1 (0.54) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL8422413 | 0.88 | MAPT (0.56) | MAPTALDH1A1MEN1KMT2AGAA | |
| SCHEMBL13292848 | 0.86 | MAPT (0.58) | MAPTALDH1A1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0968538-A1 | POLYMER SEMICONDUCTOR DEVICE COMPRISING AT LEAST A RECTIFYING FUNCTION AND METHOD FOR MAKING SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE ( CEA) (FR) | 2000-01-05 | — | — | EP | claimed |
| WO-1998035393-A1 | POLYMER SEMICONDUCTOR DEVICE COMPRISING AT LEAST A RECTIFYING FUNCTION AND METHOD FOR MAKING SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1998-08-13 | — | — | WO | claimed |
| US-8476336-B2 | Ophthalmologic composition and ophthalmologic lens | ACRI.TEC GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| US-8476336-B2 | Ophthalmologic composition and ophthalmologic lens | ACRI.TEC GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| EP-2199834-B1 | Ophthalmological composition and ophthalmologic lens | ZEISS CARL MEDITEC AG (DE) | 2012-07-25 | — | — | EP | disclosed |
| EP-2199834-B1 | Ophthalmological composition and ophthalmologic lens | ZEISS CARL MEDITEC AG (DE) | 2012-07-25 | — | — | EP | disclosed |
| US-20100160482-A1 | Ophthalmologic Composition And Ophthalmologic Lens | CARL ZEISS MEDITEC AG (DE) | 2010-06-24 | — | — | US | disclosed |
| US-20100160482-A1 | Ophthalmologic Composition And Ophthalmologic Lens | CARL ZEISS MEDITEC AG (DE) | 2010-06-24 | — | — | US | disclosed |
| EP-2199834-A1 | Ophthalmological composition and ophthalmologic lens | *Acri. Tec GmbH (DE) | 2010-06-23 | — | — | EP | disclosed |
| EP-2199834-A1 | Ophthalmological composition and ophthalmologic lens | *Acri. Tec GmbH (DE) | 2010-06-23 | — | — | EP | disclosed |
| EP-0711768-B1 | BENZIMIDAZOLE DERIVATIVE | MITSUI CHEMICALS INC (JP) | 2002-02-13 | — | — | EP | disclosed |
| US-6248739-B1 | DNA POLYMERASE INHIBITORS EFFECTIVE AGAINST HERPESVIRUSES | PHARMACIA & UPJOHN COMPANY | 2001-06-19 | — | — | US | disclosed |
| EP-0711768-A1 | BENZIMIDAZOLE DERIVATIVE | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0478268-B1 | Polymerizable substituted amide compound, polymer obtained therefrom and nonlinear optical material using the same | NIPPON PAINT CO LTD (JP) | 1995-11-15 | — | — | EP | disclosed |
| US-5411842-A | Electrolyzing p-nitroso-, azo-, nitroso-, or carbamato-N-substituted aniline derivatives; preservative-free | EASTMAN KODAK COMPANY (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0620485-A2 | Method of making a photographic developer solution | KODAK LIMITED (GB) | 1994-10-19 | — | — | EP | disclosed |
| US-5274061-A | A 4-nitophenylaminoimido pendant group oriented by an electric field | NIPPON PAINT CO., LTD. (JP) | 1993-12-28 | — | — | US | disclosed |
| US-5200552-A | POLYMERIZABLE SUBSTITUTED AMIDE COMPOUND, POLYMER OBTAINED THEREFROM AND NONLINEAR OPTICAL MATERIAL USING THE SAME | NIPPON PAINT CO., LTD. (JP) | 1993-04-06 | — | — | US | disclosed |
| EP-0478268-A1 | Polymerizable substituted amide compound, polymer obtained therefrom and nonlinear optical material using the same | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160482-A1 | Ophthalmologic Composition And Ophthalmologic Lens | NR2E3, NR1H2, NR5A2 | MAPT 2745/4885ALDH1A1 2628/4885MEN1 2151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.